Thomas MacArthur bought Vertex Pharmaceuticals Inc (NASDAQ: VRTX)
Thomas MacArthur (R-NJ), a U.S. Representative, has disclosed 3 trades in Vertex Pharmaceuticals Inc (VRTX) since 2016, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thomas MacArthur bought $1,001 - $15,000 of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on November 1, 2016. Since that trade, VRTX is up +520.61% against the S&P 500 up +302.77%, an outperformance of +217.84%.
Across these filings, Thomas MacArthur has been a net buyer of VRTX (a buy-to-sell ratio of 2.00). The most recent disclosed VRTX transaction shown was dated November 2, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Thomas MacArthur's VRTX trades vs the price
VRTX is up +520.61% since Thomas MacArthur bought on November 1, 2016, versus +302.77% for the S&P 500.
Performance since this trade
All Thomas MacArthur VRTX trades
Thomas MacArthur & VRTX trading FAQ
Is it legal for Thomas MacArthur to trade Vertex Pharmaceuticals Inc (VRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas MacArthur buy VRTX?
Thomas MacArthur disclosed a purchase of $1,001 - $15,000 of Vertex Pharmaceuticals Inc (VRTX) on November 1, 2016, according to public STOCK Act filings.
How has VRTX performed since Thomas MacArthur's trade?
Since Thomas MacArthur bought VRTX on November 1, 2016, the stock is up +520.61%, versus +302.77% for the S&P 500 over the same period, an outperformance of +217.84%.
How many times has Thomas MacArthur traded VRTX?
Thomas MacArthur has disclosed 3 VRTX trades since 2016 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRTX trades?
Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Thomas MacArthur's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncThomas MacArthur's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.